Sharon Bio-Medicine Limited - chemicals in Panvel, Maharashtra, India. FY 2026 financials & compliance.
CIN U24110MH1989PLC052251 Incorporated 19 June 1989 ROC Mumbai HQ Panvel, Maharashtra, India
Active Public Limited Company chemicals
Revenue · FY 2025
₹204.22 Cr
▼ 20% YoY
Net profit · FY 2025
₹23.18 Cr
Net margin 11.4%
EBITDA · FY 2025
₹51.37 Cr
EBITDA margin 25.2%
Authorised capital
₹35 Cr
Registered with MCA
Paid-up capital
₹47,952
Issued & subscribed
Open charges
₹25 Cr
Satisfied ₹2,595.42 Cr
Company age
37 yrs
Est. 1989
Employees · EPFO
258
Provident fund records

About Sharon Bio-Medicine Limited

Data last updated:

Sharon Bio-Medicine Limited is a public limited company based in Panvel, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 19 June 1989 and has been in existence for over 37 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH1989PLC052251. Its GSTIN is 27AAACS8457L1ZS (Maharashtra). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹35 Cr and a paid-up capital of ₹47,952. It was formerly known as Sharon Synthochem Private Limited. It is led by directors including Mukeshkumar Siyaram Singh (Whole-Time Director) and Purushottam Sharma.

Its last annual general meeting (AGM) was held on 24 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Panvel, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹204.22 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹23.18 Cr (net margin 11.4%) and EBITDA of ₹51.37 Cr (EBITDA margin 25.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.

The company has about 258 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Sa-Ford and Sharon Bio. As per MCA filings, the company has open charges of ₹25 Cr and satisfied charges of ₹2,595.42 Cr on record. Court records list 105 cases involving the company, including 22 filed by the company and 83 filed against it; 30 cases are pending. The company has 11 deals on record (8 market trades, 3 funding rounds), with disclosed funding of ₹83.58 Cr; the latest was in June 2023. Its 10 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Aktinos Pharma Private Limited with revenue of ₹207.85 Cr.

The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website sharonbio.com.

Company details

CIN U24110MH1989PLC052251
Registration Number 052251
Incorporation Date 19 June 1989
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Non-Compliant

CIN history

Sharon Bio-Medicine has one previous CIN (Corporate Identification Number): L24110MH1989PLC052251. The current CIN is U24110MH1989PLC052251, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24110MH1989PLC052251Current
L24110MH1989PLC052251Previous

Contact details

Sharon Bio-Medicine Limited's registered office is in Panvel, Maharashtra.

  • Social Media
  • Registered Address
    Plot No. L6, MIDC Road, Panvel, Maharashtra, India – 410208
  • Industry
    Chemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
Comprehensive company report
Sharon Bio-Medicine Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Sharon Bio-Medicine operates two associated brands: SA-FORD and Sharon Bio. Each brand links to its own profile.

BrandDescriptionWebsite
Provides chemistry, toxicology testing, and regulatory studies for clients.sa-ford.com
Manufacturer of pharmaceutical intermediates, actives, and finished dosagessharonbio.com

Business activity

The main business activity of Sharon Bio-Medicine is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Sharon Bio-Medicine Limited, buy the company report.

Financials of Sharon Bio-Medicine Limited

FY 2025 filings available

Sharon Bio-Medicine Limited reported revenue of ₹204.22 Cr (down 20% YoY) for FY 2025.

Revenue · FY 2025
₹204.22 Cr ▼ 20%
Net profit · FY 2025
₹23.18 Cr margin 11.4%
EBITDA · FY 2025
₹51.37 Cr margin 25.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 20%
3 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 44%
3 years · compounded
▲ 21%

Revenue fell 20% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹51.37 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹23.18 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin25.2%
Net Profit Margin11.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sharon Bio-Medicine Limited, buy the company report.

Board of directors of Sharon Bio-Medicine Limited

Sharon Bio-Medicine has 4 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Purushottam SharmaDirector17 Jun 20233 Years 5 MonthsCurrent
Mukeshkumar Siyaram SinghWhole-Time Director17 Jun 20233 Years 5 MonthsCurrent
Mahendar KorthiwadaDirector29 Nov 20232 Years 11 MonthsCurrent
Jayant Vasudeo RaoDirector17 Jun 20233 Years 5 MonthsCurrent

Peer comparison

Sharon Bio-Medicine Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Aktinos Pharma Private Limited₹207.85 Cr (FY 2024)18.0%Hyderabad, Telangana, India
Nifty Labs Private Limited₹206.98 Cr (FY 2025)30.0%Aran Road, Ameerpet, Hyd-016, Telangana, India
Inogent Laboratories Private Limited₹206.9 Cr (FY 2017)18.0%Hyderabad, Telangana, India
Smilax Laboratories Limited₹206.57 Cr (FY 2025)-25.0%Hyderabad, Telangana, India
Swati Spentose Private Limited₹205.55 Cr (FY 2024)11.0%Mumbai, Maharashtra, India
Sharon Bio-Medicine Limitedthis company₹204.22 Cr (FY 2025)₹23.18 Cr11.4%-20.0%Panvel, Maharashtra, India
Orch Laboratories India Private Limited₹203 Cr (FY 2025)5.0%Hyderabad, Telangana, India
Melody Healthcare Private Limited₹200.91 Cr (FY 2025)16.0%Mumbai, Maharashtra, India
ZCL Chemicals Limited₹199.89 Cr (FY 2019)8.0%Mumbai, Maharashtra, India
Shree Jee Laboratory Private Limited₹198.78 Cr (FY 2024)-2.0%New Delhi, Delhi, India
Daffodil Pharmachem Private Limited₹196.29 Cr (FY 2025)-27.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Sharon Bio-Medicine Limited, buy the company report.

Charges & borrowings

Open charges
₹25 Cr
Satisfied charges
₹2,595.42 Cr
Breakdown by lending institutions
State Bank of India₹25.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Jul 2025101157919State Bank of India₹25 CrOpen
09 Sep 201510616310State Bank of India₹137.49 CrSatisfied
30 Mar 201510565945Sbicap Trustee Company Limited₹683.14 CrSatisfied
29 Dec 201410543298Canara Bank₹9 CrSatisfied
27 Sep 201410524338Union Bank of India₹6.6 CrSatisfied

To see the full charge records of Sharon Bio-Medicine Limited, buy the company report.

Total charge records: 33 View all charges

Deals & funding

Sharon Bio-Medicine Limited has 11 deals on record (8 market trades, 3 funding rounds), with disclosed funding of ₹83.58 Cr; the latest was in June 2023.

Total deals
11
Market trades
8
Funding rounds
3
Disclosed funding
₹83.58 Cr

Deals on record (5 of 11)

WhenDealAmountParties
Jun 2023Funding round₹1 CrInvestors: Univentis Medicare Limited , Univentis Medicare Limited & Manoj Kumar Lohariwala, Univentis Medicare Limited & Vinay Kumar Lohariwala
Mar 2019Market trade₹22.3 LakhBuyer: an individual
Seller: Twin Earth Securities Private Limited
Sep 2016Market trade₹89.8 LakhBuyer: NBN Fintrade Private Limited
Seller: NBN Fintrade Private Limited
Mar 2015Funding round₹66.83 CrInvestors: Venus Global Management & Consultancy Services Private Limited , Ramco Properties Private Limited , Bagulvani General Trading Private Limited
Mar 2011Market trade₹99.1 LakhBuyer: Labh Capital Services Limited
Seller: Sajal Finance and Investments Private Limited

To see the full deal history of Sharon Bio-Medicine Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sharon Bio-Medicine Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Sharon Bio-Medicine has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
27AAACS8457L1ZSMaharashtraActive01 Jul 2017
05AAACS8457L1ZYUttarakhandActive01 Jul 2017

To see the full GST registrations and return filing status of Sharon Bio-Medicine Limited, buy the company report.

Recent activity

Sharon Bio-Medicine Limited has 22 board changes on record since 2007: 4 appointments and 18 cessations. The latest: Kaushik Kamalapada Banerjee ceased to be Manager on 30 Apr 2025.

Charges
A charge with State Bank Of India amounted to Rs. 25.00 Cr with Charge ID 101157919 was registered on 31 Jul 2025.
AGM
Sharon Bio-Medicine Limited last Annual general meeting of members was held on 24 Jul 2025 as per latest MCA records.
Ceased
Kaushik Kamalapada Banerjee ceased to be Manager.
Filing
Sharon Bio-Medicine Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Mahendar Korthiwada ceased to be Additional Director.
Appointed
Mahendar Korthiwada was appointed as Director.
Charges
A charge registered on 06 Mar 2012 via Charge ID 10349324 with Srei Equipment Finance Private Limited was fully satisfied on 02 Nov 2023.
Charges
A charge registered on 30 Mar 2015 via Charge ID 10565945 with Sbicap Trustee Company Limited was fully satisfied on 09 Aug 2023.
Charges
A charge registered on 05 Dec 2013 via Charge ID 10467312 with Sbicap Trustee Company Limited was fully satisfied on 09 Aug 2023.
Charges
A charge registered on 27 Mar 2010 via Charge ID 10213673 with Others was fully satisfied on 21 Jul 2023.
Charges
A charge registered on 29 Jan 2010 via Charge ID 10200416 with Others was fully satisfied on 21 Jul 2023.
Charges
A charge registered on 20 Apr 2012 via Charge ID 10351226 with Siemens Financial Services Private Limited was fully satisfied on 12 Jul 2023.

94 earlier events are in the company report.

Frequently asked questions

Sharon Bio-Medicine is an active public limited company based in Panvel, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 19 June 1989 (37+ years old) and is registered under CIN U24110MH1989PLC052251.

Sharon Bio-Medicine has 4 current directors:

The latest financial statements of Sharon Bio-Medicine on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 July 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Sharon Bio-Medicine is 27AAACS8457L1ZS, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAACS8457L1ZY (Uttarakhand).

The CIN (Corporate Identification Number) of Sharon Bio-Medicine is U24110MH1989PLC052251. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sharon Bio-Medicine has 105 court cases on record: 22 filed by the company and 83 filed against it. 30 are pending. Most are in the district courts.

Sharon Bio-Medicine was incorporated on 19 June 1989, making it 37+ years old. It is registered with the Registrar of Companies, Mumbai.

Sharon Bio-Medicine has 11 deals on record (8 market trades, 3 funding rounds), with disclosed funding of ₹83.58 Cr; the latest was in June 2023.

The peers of Sharon Bio-Medicine by revenue are Aktinos Pharma Private Limited, Nifty Labs Private Limited, Inogent Laboratories Private Limited, Smilax Laboratories Limited, Swati Spentose Private Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Kaushik Kamalapada Banerjee ceased to be Manager on 30 Apr 2025. Mahendar Korthiwada ceased to be Additional Director on 09 Sep 2024. Mahendar Korthiwada was appointed as Director on 29 Nov 2023. Sharon Bio-Medicine has 22 board changes on record in total.

Sharon Bio-Medicine can be reached through the website sharonbio.com. Its registered office is in Panvel, Maharashtra, India.